Zhang Can, Hu Yihe, Wan Jun, He Hongbo
Department of Orthopaedics, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China.
Oncol Rep. 2015 Oct;34(4):2195-201. doi: 10.3892/or.2015.4186. Epub 2015 Aug 10.
MicroRNAs (miRs) have been implicated in tumorigenesis through inhibition of the expression of their target genes at post-transcriptional levels. miR-124 has been found to be downregulated in many malignant tumors including osteosarcoma (OS). However, the detailed mechanism of miR-124 in the regulation of OS malignant phenotypes remains largely unclear. Here we aimed to explore the role of miR-124 in mediating OS cell migration and invasion, as well as the underlying regulatory mechanisms. Real-time RT-PCR data showed that miR-124 was frequently downregulated in OS cell lines compared to normal human osteoblast cells. We further conducted bioinformatic analysis and a luciferase reporter assay, and identified receptor tyrosine kinase-like orphan receptor 2 (ROR2) as a novel target of miR-124. Furthermore, we found that ROR2 was significantly upregulated in OS cell lines compared to normal human osteoblast cells, and miR-124 negatively mediated the protein level of ROR2 in U-2OS and Saos-2 cells. Moreover, transfection with miR-124 mimics significantly suppressed migration and invasion in the U-2OS and Saos-2 cells, while overexpression of ROR2 in the miR-124-transfected OS cells reversed the inhibitory effect of miR-124 upregulation on OS cell migration and invasion. In addition, we found that overexpression of miR-124 significantly suppressed the activity of non-canonical Wnt signaling, downstream of ROR2. Based on these findings, we suggest that miR-124 may inhibit OS metastasis, partly at least, via targeting ROR2 and thus suppressing the activity of ROR2-mediated non-canonical Wnt signaling.
微小RNA(miR)通过在转录后水平抑制其靶基因的表达而与肿瘤发生有关。已发现miR-124在包括骨肉瘤(OS)在内的许多恶性肿瘤中表达下调。然而,miR-124调节OS恶性表型的详细机制仍不清楚。在这里,我们旨在探讨miR-124在介导OS细胞迁移和侵袭中的作用以及潜在的调控机制。实时RT-PCR数据显示,与正常人成骨细胞相比,miR-124在OS细胞系中经常下调。我们进一步进行了生物信息学分析和荧光素酶报告基因检测,并确定受体酪氨酸激酶样孤儿受体2(ROR2)是miR-124的一个新靶点。此外,我们发现与正常人成骨细胞相比,ROR2在OS细胞系中显著上调,并且miR-124在U-2OS和Saos-2细胞中负向调节ROR2的蛋白水平。此外,用miR-124模拟物转染可显著抑制U-2OS和Saos-2细胞的迁移和侵袭,而在miR-124转染的OS细胞中过表达ROR2可逆转miR-124上调对OS细胞迁移和侵袭的抑制作用。此外,我们发现miR-124的过表达显著抑制了ROR2下游非经典Wnt信号的活性。基于这些发现,我们认为miR-124可能至少部分地通过靶向ROR2并因此抑制ROR2介导的非经典Wnt信号的活性来抑制OS转移。